Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-30 00:00:00 ET · period of report 2021-08-26 · accession 0001237899-21-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-08-30 | 2021-08-26+ | REGN | SING GEORGE L | Dir | S - Sale | $671.29 | -700 | 1,000 | -41% | -$469.9K |
| M | 2021-08-30 | 2021-08-30 | REGN | SING GEORGE L | Dir | S - Sale | $672.50 | -1,000 | 42.9K | -2% | -$672.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | S | D | 300 | $672.00 | 1,750 | I | — | — | |
| 2 | Common | Common Stock | 2021-08-30 | S | D | 500 | $670.00 | 43,358 | D by Spouse | — | — | |
| 3 | Common | Common Stock | 2021-08-30 | S | D | 250 | $670.00 | 750 | I | — | — | |
| 4 | Common | Common Stock | 2021-08-30 | S | D | 500 | $675.00 | 42,858 | D by Spouse | — | — | |
| 5 | Common | Common Stock | 2021-08-26 | S | D | 150 | $672.00 | 1,000 | I by Trust for Son | — | — |